UK Markets closed

LENSAR, Inc. (LNSR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
7.11-0.20 (-2.74%)
As of 04:00PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close7.31
Open7.22
Bid7.05 x 1300
Ask7.35 x 800
Day's range7.11 - 7.33
52-week range6.13 - 9.83
Volume3,904
Avg. volume8,611
Market cap77.731M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Business Wire

    LENSAR to Present at Two Upcoming Investor Conferences

    ORLANDO, Fla., November 16, 2021--LENSAR, Inc. (NASDAQ: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced Nick Curtis, Chief Executive Officer will present at two upcoming investor conferences:

  • Business Wire

    LENSAR Announces Poster Presentations at the American Academy of Ophthalmology

    ORLANDO, Fla., November 12, 2021--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that two posters have been accepted for virtual presentation at the Annual Meeting of the American Academy of Ophthalmology (AAO) being held November 12-15, 2021.

  • Business Wire

    LENSAR Reports Third Quarter 2021 Financial Results and Provides Business Update

    ORLANDO, Fla., November 08, 2021--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the quarter ended September 30, 2021 and provided an update on key strategic and operational initiatives.